Bristol Myers Squibb stock heads into the open after a 0.2% dip
Published on 09/17/2026 at 08:26 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Bristol Myers Squibb stock closed at USD 63.60 on the New York Stock Exchange on September 16, 2026, down 0.2% from the prior session in regular trading. Compared with the Dow Jones Industrial Average, which declined 1.21% to 51,462.55 points on September 16, 2026, the share price move was milder.
September 16, 2026 in numbers
Bristol Myers Squibb Co. (ISIN US0897961004, NYSE: BMY) ended the September 16, 2026 session at USD 63.60 on the New York Stock Exchange, representing a 0.2% loss versus the previous close, according to closing data cited by MarketScreener. The intraday trading range that day ran between approximately USD 63.54 and USD 63.73, placing the closing price near the middle of the day’s band and within a few dollars of recent analyst target levels. On the same day, the Dow Jones Industrial Average fell 1.21% to 51,462.55 points, indicating a broader equity market decline that slightly outpaced the move in Bristol Myers Squibb shares.
As MarketScreener reported on September 16, 2026, the company’s Board of Directors declared a quarterly dividend of USD 0.63 per share, payable on November 2, 2026 to shareholders of record as of October 2, 2026, a shareholder return decision that framed trading sentiment in the latest session.
Dividend and earnings dates today
The fresh dividend declaration remains in focus today as investors assess Bristol Myers Squibb’s income profile heading into the open, with the USD 0.63 per share payment scheduled for November 2, 2026 and the record date set at October 2, 2026, according to Investing.com. In addition, the next key reporting milestone is the third quarter 2026 earnings release, which is scheduled for October 28, 2026, as noted by MarketScreener, giving the stock a defined timetable for the next fundamental update.
